Lung Cancer - Journal - Elsevier.

Check out new collections focusing on breast cancer, immunotherapy, solid tumors, and gastrointestinal cancer! CCR Translation. A New CDK9 Inhibitor on the Block to Treat Hematologic Malignancies, Clara Alcon, et al. Clinical Trials: Targeted Therapy. HIF-2 Complex Dissociation, Target Inhibition, and Acquired Resistance with PT2385, a First-in.

Full research papers should be as concise as possible, without sacrificing documentation of results. Manuscripts containing pertinent and interesting observations concerning cancer research in general, reports on new observations, or studies that do not warrant publication as a full research article will be considered as Short Reports.

For Clinical Cancer Research only, a 150-word statement of translational relevance describing how the results might be applied to the future practice of cancer medicine, should be provided on a page between the title page and abstract. The abstract must be concise, yet should accurately outline the content of the manuscript (see the Categories.

Authors submitting to the journal receive a first decision within an average of 5.09 weeks The aim of Cancer Genetics is to publish high quality scientific papers on the cellular, genetic and molecular aspects of cancer, including cancer predisposition and clinical diagnostic applications.

Breast Cancer Research is the highest ranking breast cancer-specific title in the top quartile of oncology journals worldwide.. 173 days from submission to acceptance 30 days from acceptance to publication. Citation Impact 5.676 - 2-year Impact Factor 6.302 - 5-year Impact Factor 1.77 - Source Normalized Impact per Paper (SNIP) 2.874.

Upon submission, authors will be asked to identify the type of article. ecancermedicalscience accepts the following: Research Papers - Research articles have no page or word limit and may be in the areas of laboratory science, epidemiology, translational medicine, clinical trial reports (with positive or negative results) or nursing research.

Cancer Research is the most frequently cited cancer journal in the world. Cancer Research seeks manuscripts that offer pathobiological and translational impact to inform the personal, clinical, and societal problems posed by cancer.

Breast Cancer Research is an international, peer-reviewed online journal, publishing original research, reviews, editorials and reports. Open access research articles of exceptional interest are published in all areas of biology and medicine relevant to breast cancer, including normal mammary gland biology, with special emphasis on the genetic, biochemical, and cellular basis of breast cancer.

Breast Cancer: Basic and Clinical Research is an international, peer-reviewed, open access journal that covers all aspects of research and treatment of breast cancer. The journal aims to promote understanding of breast cancer biology and pathogenesis, clinical interventions, and epidemiology and population genetics.

Thank you for your submission to learn more about becoming a cancer research partner. One of our specialists will be in touch with you shortly. What cancer patients, their families, and caregivers need to know about the coronavirus. How COVID-19 is impacting our patient services.

Supportive Care in Cancer publishes papers devoted to medical, technical and surgical topics as they relate to supportive therapy and care that supplements or substitutes basic cancer treatment at all stages of the disease. The journal focuses on papers and reviews that report on intervention studies and policy-related issues to manage treatment-related toxicities and other supportive care.

Original research articles, early reports, review articles, editorials and correspondence covering the prevention, epidemiology and etiology, basic biology, pathology, clinical assessment, surgery, chemotherapy, radiotherapy, combined treatment modalities, other treatment modalities and outcomes of lung cancer are welcome. All original papers.